Company news
Cardiol Therapeutics Inc. news in 2020
Cardiol Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)
December 22, 2020
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
December 15, 2020
Cardiol Therapeutics' Cortalex(TM) CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
October 20, 2020
FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com
September 30, 2020
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial
September 25, 2020
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
September 15, 2020
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM)
August 26, 2020
Heart Health and COVID-19: Fighting Inflammation May be Key -- SECFilings.com
July 15, 2020
Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing
July 10, 2020
Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th
July 7, 2020
Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor
June 29, 2020
David Elsley Files Early Warning Report for Cardiol Therapeutics
June 25, 2020
Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option
June 4, 2020
Cardiol Therapeutics Reports 2020 AGM Results
June 2, 2020
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4: 30 p.m. EDT
May 29, 2020
Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering
May 14, 2020
Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering
May 13, 2020
Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19
May 6, 2020
Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart
April 14, 2020
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure
April 1, 2020
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A
March 26, 2020
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.
March 18, 2020
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation
March 5, 2020
Cardiol Therapeutics' Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada
January 15, 2020